Improving Statin Noncompliance: If You Build It, Will They Come?

Few things are as certain in cardiology as the knowledge that statins reduce cardiovascular (CV) events in at-risk individuals. Statins have significantly reduced the risk of death, myocardial infarction, stroke, and the need for coronary revascularization in dozens of high-quality clinical trials.1Baigent C. Blackwell L. et al.Cholesterol Treatment Trialists’ CollaborationEfficacy and safety of more intensive lowering of LDL cholesterol: a...